insights_auto
Outlook: 53.3% bullish·6.7% bearish
Go to analysischevron_right
DTIL:NASDAQ
Precision BioSciences Inc
$9.50
arrow_downward
-1.86%(-0.18) 1D
$9.50
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 10, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DTIL...
Open
$9.60
High
$10.02
Low
$9.22
Mkt. cap
362.22M
Avg. vol.
362.55K
Volume
352.81K
52-wk high
$10.81
52-wk low
$3.53
EPS
-$1.23
Beta
1.35
Shares outstanding
27.94M
No. of employees
69
Open
$9.60
High
$10.02
Low
$9.22
Mkt. cap
362.22M
Avg. vol.
362.55K
Volume
352.81K
52-wk high
$10.81
52-wk low
$3.53
EPS
-$1.23
Beta
1.35
Shares outstanding
27.94M
No. of employees
69
News stories
From web sources and news partners
The Business Journals
·
1 day ago
Durham biotech raises $125M as it seeks breakthrough gene therapies
Profile
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
About Precision BioSciences Inc
CEO-
Employees69
Founded2006
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteprecisionbiosciences.com